Clinical Trial Update: CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating CD70-CAR-NK cell therapy for relapsed/refractory T-cell lymphoma and relapsed/refractory acute myeloid leukemia, whi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• T-cell Lymphoma

Drugs mentioned

• CD70-CAR-NK Cell Therapy

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Relapsed/refractory T-cell Lymphoma, Relapsed/refractory Acute Myeloid Leukemia | Phase 1 | Status: NOT_YET_RECRUITING